3-[123I]-α-methyl-l-tyrosine (IMT) is an artificial amino acid that is transported through SLC7A5 [175] and is also a suitable metabolic indicator for SPECT in extracranial tumors, including breast cancer [176]. The gene discussed is SLC7A5; the disease is breast cancer.